As of today (2024-04-24), BioGaia AB's share price is kr117.21129.
BioGaia AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr4.20. Hence, BioGaia AB's Price-to-Operating-Cash-Flow Ratio for today is 27.93.
The historical rank and industry rank for BioGaia AB's Price-to-Operating-Cash-Flow or its related term are showing as below:
LTS:0GTN'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 16.69 Med: 38.73 Max: 167.36
Current: 28.48
During the past 13 years, BioGaia AB's highest Price-to-Operating-Cash-Flow Ratio was 167.36. The lowest was 16.69. And the median was 38.73.
BioGaia AB's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was kr1.21.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was kr4.20.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of BioGaia AB was 33.60% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 19.40% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 16.00% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 12.20% per year.
During the past 13 years, BioGaia AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 138.40% per year. The lowest was -29.60% per year. And the median was 19.45% per year.
BioGaia AB Price-to-Operating-Cash-Flow Historical Data
The historical data trend for BioGaia AB's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
BioGaia AB Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
50.18 |
43.34 |
47.16 |
26.46 |
23.99 |
|
BioGaia AB Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
26.46 |
28.55 |
34.30 |
25.86 |
23.99 |
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioGaia AB Price-to-Operating-Cash-Flow Distribution
For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where BioGaia AB's Price-to-Operating-Cash-Flow falls into.
BioGaia AB Price-to-Operating-Cash-Flow Calculation
BioGaia AB's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 117.21129 | / | 4.196 |
| = | 27.93 |
BioGaia AB's Share Price of today is kr117.21129.
BioGaia AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.20.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
BioGaia AB (LTS:0GTN) Business Description
Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.
BioGaia AB (LTS:0GTN) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0GTN has been successfully added to your